the improvement of the bioavailability of a drug (i.e., by enhancing absorption and/or inhibiting metabolism)
Explanation:
Beneficial pharmacokinetic interactions include the improvement of the bioavailability of a drug (i.e., by enhancing absorption and/or inhibiting metabolism) or prolongation of a drug's plasma level within its therapeutic window (i.e., by decreasing excretion), whereas beneficial pharmacodynamic interactions include
